Nano-biosensors integrated with machine learning for non-invasive monitoring of breast cancer recurrence

Nano-biosensors have upended the approach of measuring breast cancer recurrence in a non-invasive way because it can detect biomolecular changes at very tiny levels in the patient samples. The study reviewed the use of nano-biosensor technology in conjunction with machine learning algorithms to predict recurrence risk based on multi-parametric biomarker data. The features of population of patients, i.e., circulating tumor cells, exosome population, miRNA expression, protein biomarkers, and biosensor-detected electrochemical and optical signals were modeled by creating a synthetic dataset. To perform better prediction, demographic and clinical factors, i.e., age of the patient, body mass index, and treatment history, were also included. Thus, the machine learning model is based on such correlations of these biosensor-derived features and the recurrence risk, which allows for estimating the likelihood of diseases returning. Correlations showed that the major outputs of the nano-biosensors such as electrochemical and optical signals are significantly correlated (0.5-0.8) with the recurrence probability, which confirms their value as predictive signals. Scatter plot and distribution graphs also identified trends and variations of the patient sub-groups, indicating the nano-biosensor data ability to be used to stratify patients and monitor them individually. This method offers a scalable, non-invasive method of early cancer recurrence detection in the breast through convergence between nano-biosensor measurements and sophisticated predictive modeling strategies. This promises to change patient outcomes by improving nanoscale diagnostics and permitting constant patient monitoring without invasive approaches. This paper has proven that features based on nano-biosensors combined with machine learning can attain moderate to high predictive power with respect to breast cancer recurrence risks, thus showing non-invasive monitoring on a nanoscale is promising.